ERIN WELDEN: Open Payments
NPI 1376813535 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 34 payments from 17 companies in 2025. Trend: 2023 $1,283 · 2024 $2,324 · 2025 $1,272
Food & beverage: $1,255Education: $17
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $399 |
| United Therapeutics Corporation | 4 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| GENZYME CORPORATION | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Pulmonx Corporation | 2 | $59 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $44 |
| Insmed, Inc. | 2 | $39 |
| Verona Pharma, Inc. | 1 | $30 |
Products named: UPTRAVI, Tyvaso, Kerendia, DUPIXENT, CHARTIS CATHETER, NUCALA, LUMRYZ, Ohtuvayre.
Industry payments across NC — which companies pay providers there.
